We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLA
501
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.35M 0.03%
98,300
-96,000
-49% -$2.65M
ADVM
502
DELISTED
Adverum Biotechnologies
ADVM
$2.3M 0.02%
+20,000
New +$1.76M
CNC icon
503
Centene
CNC
$31.6B
$2.3M 0.02%
+34,181
New +$1.85M
ORLY icon
504
O'Reilly Automotive
ORLY
$75.1B
$2.27M 0.02%
77,685
-11,415
-13% -$327K
FAST icon
505
Fastenal
FAST
$54.7B
$2.22M 0.02%
120,092
+2,990
+3% +$53.4K
WAIR
506
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$2.21M 0.02%
+201,017
New +$2.21M
PHM icon
507
Pultegroup
PHM
$24.9B
$2.19M 0.02%
56,501
+13,225
+31% +$514K
KR icon
508
Kroger
KR
$35.5B
$2.19M 0.02%
75,458
-4,697
-6% -$125K
CHL
509
DELISTED
China Mobile Limited
CHL
$2.19M 0.02%
51,750
+7,250
+16% +$293K
MTD icon
510
Mettler-Toledo International
MTD
$27B
$2.19M 0.02%
2,754
-32
-1% -$23.1K
HAL icon
511
Halliburton
HAL
$26.8B
$2.17M 0.02%
88,748
-24,339
-22% -$513K
DVA icon
512
DaVita
DVA
$15.2B
$2.17M 0.02%
28,866
+21,895
+314% +$1.45M
WDAY icon
513
Workday
WDAY
$36.4B
$2.17M 0.02%
13,169
+332
+3% +$55.1K
SCI icon
514
Service Corp International
SCI
$11.4B
$2.14M 0.02%
46,467
+31,959
+220% +$1.44M
NTRS icon
515
Northern Trust
NTRS
$22.4B
$2.13M 0.02%
20,004
-529
-3% -$54.1K
PACB icon
516
Pacific Biosciences
PACB
$422M
$2.12M 0.02%
411,991
+80,636
+24% +$410K
ITUB icon
517
Itaú Unibanco
ITUB
$92.3B
$2.12M 0.02%
317,797
+83,184
+35% +$521K
BXP icon
518
Boston Properties
BXP
$11B
$2.11M 0.02%
15,334
-610
-4% -$82.2K
FRC
519
DELISTED
First Republic Bank
FRC
$2.11M 0.02%
17,990
-5,031
-22% -$543K
IEX icon
520
IDEX
IEX
$16.6B
$2.09M 0.02%
12,149
+2,435
+25% +$394K
SRCI
521
DELISTED
SRC Energy Inc
SRCI
$2.08M 0.02%
504,363
+288,331
+133% +$1.09M
MRO
522
DELISTED
Marathon Oil Corporation
MRO
$2.06M 0.02%
151,958
+5,061
+3% +$61.7K
DOV icon
523
Dover
DOV
$27.7B
$2.06M 0.02%
17,877
-2,971
-14% -$318K
CWT icon
524
California Water Service
CWT
$3.04B
$2.06M 0.02%
39,893
+32,075
+410% +$1.67M
MCHI icon
525
iShares MSCI China ETF
MCHI
$6.14B
$2.06M 0.02%
32,000
-10,000
-24% -$598K

Similar funds

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.